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Parting Thoughts
f r o m

t h e

O u t g o i n g

On June 1, the day after New
York Medical College cele
brates its 153rd Commence
ment in Carnegie Hall, I will
step down as dean of the
School of Medicine. As I plan
to tell some 362 graduates
and their families and friends,
the first time I went to medical
school it took me only four
years to get through; this time
it required sixteen. You do slow down as you get older, but in
my defense, medical education is much more complex today.
The 174 newly minted physicians of the Class of 2012 matched
in twenty medical specialties at strong teaching hospitals
around the country. We are very proud of our graduates; they
will enhance the reputation of New York Medical College
wherever they go. The about-to-enter Class of 2016 is shaping
up as I write this. From more than 11,000 applicants, 1,400
were selected to interview for admission to a class of 190.
Their personal characteristics, diversity and academic creden
tials predict a very strong class, and we are glad to note that
our robust applicant pool—among the largest in the nation—
allows us to select the very best candidates.
The last two years have presented the College with challenges
and opportunities. When Saint Vincent’s Hospital in Manhattan
closed in 2010, we were required to reassign 50 medical students
to clerkships at other teaching hospitals and to place 300
“orphaned” residents in GME programs. It was a monumental
challenge that was successfully met thanks to the cooperation
of our teaching affiliates, Westchester Medical Center and
Metropolitan Hospital Center. Helping to ease the burden were
new or expanded affiliations with Keller Army Hospital at West
Point, Lenox Hill Hospital in New York City, Phelps Memorial
Hospital Center in Sleepy Hollow, N.Y., and Saint Joseph’s
Health Care System in Paterson, N.J. This complicated logisti
cal exercise would not have been possible without the support
of our clinical chairs, program directors and the good will of
organized medicine. I want to express my gratitude to Paul M.
Wallach, M.D., vice dean for medical education, Richard G.
McCarrick, M.D., vice dean for graduate medical education
and affiliations, and Gladys M. Ayala, M.D., M.P.H., senior
associate dean for student affairs, for playing key roles in the
effort, which provided the opportunity to explore new models
for the curriculum.
The transition from sponsorship by the Archdiocese of New
York to the Touro College and University System was com
pleted this academic year. This historic undertaking was carried
out in the best academic tradition of collegiality, with input from
faculty, administration and students. Alan H. Kadish, M.D.,

D e a n

Touro’s president, was appointed president of New York
Medical College. Following a nationwide academic search,
a candidate was selected to lead New York Medical College
into the future. We are all very pleased to inform you that on
May 1, Edward C. Halperin, M.D., M.A., became chancellor
for health affairs and chief executive officer of New York
Medical College.
A graduate of Yale School of Medicine, Dr. Halperin completed
an internship in internal medicine at Stanford and his residency
at Harvard’s Massachusetts General Hospital. He spent 23
years at Duke University, where he rose to become chairman
of the Department of Radiation Oncology and vice dean of the
School of Medicine. He also earned a Master of Arts in Liberal
Studies there. Before coming to the College, Dr. Halperin was
dean of the School of Medicine at the University of Louisville.
I had the privilege of getting to know Ed when we were both
serving on the Council of Deans. I can assure you New York
Medical College is in very good hands.
Dr. Halperin will also serve as provost for biomedical affairs
at Touro, and will serve as executive dean of the School of
Medicine after I step down. With his ten years of experience as
a medical school vice dean and dean, Dr. Halperin is eminently
qualified to serve in this capacity until we begin a search for a
new dean—probably in the coming academic year.
One of the first concrete (literally and figuratively) results of the
Touro affiliation will be the construction of a new clinical skills
center, which is expected to open in 2013. Watch for more
news about this exciting development—and for more in future
issues of Chironian, both about and by Dr. Halperin, a prolific
writer and speaker who was chosen to deliver this year’s
Commencement address.
In my final weeks as dean, I received numerous calls and visits
from colleagues and students stopping by to say goodbye and
wish me the best. With great tact, I told them that I planned to
stay on the faculty, teaching in the Department of Psychiatry
and Behavioral Sciences. I have thoroughly enjoyed the honor
and challenge of serving as dean and, prior to Dr. Halperin’s
arrival, as provost. The best reward is the assurance that
during my tenure, with the unwavering support of the Board
of Trustees, department chairs, faculty and administration,
approximately 3,000 individuals received M.D. degrees from
New York Medical College, and are now in residency or prac
tice, shaping the future of medicine.
Sincerely,

Ralph A. O’Connell, M.D.
Immediate Past Provost and Dean, School of Medicine
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for Answers
Zbigniew Darzynkiewicz, M.D., Ph.D., develops the technology
and methods for understanding cell proliferation, opening doors
to more effective cancer treatment.
By Alicia M. Prater, Ph.D. ’07

T

he “War on Cancer” marked its 40th anniversary in
December—a long time in anybody’s book, but not
long enough to come up with a reliable cure for any of
the thousands of symptoms that use uncontrolled cell growth
to thrive. President Richard M. Nixon began using the metaphor
in speeches to support the National Cancer Act, a historic bill
passed at the close of 1971 to initiate federal government
spending for cancer research. Scientists and physicians could
approach their studies from the laboratory or by clinically treat
ing patients with medicinal remedies specifically designed
around their genetic make-ups in a process now called trans
lational, or bench to bedside, treatment. At New York Medical
College and affiliated Westchester Medical Center, there are
nearly 20 investigators with M.D. and Ph.D. degrees who have
spent their entire lives waging the war. One of them, Zbigniew
Darzynkiewicz, M.D., Ph.D., has been point man at the cellular
level, achieving world renown for his dogged pursuit of answers
to a puzzle: how to turn cancer cells against themselves,
instead of taking more human lives.
When a cell is damaged, chemical signals are activated that
drive the cell to die without affecting nearby healthy cells.
Knowing how to control this process, known as apoptosis,
could allow doctors to control tumor growth with little, if any,
toxicity to healthy cells. Research examining the differences
between apoptotic and normal cells uses techniques that dif
ferentiate between the molecular attributes of individual cells.

Dr. Darzynkiewicz has the distinction of being a pioneer in the
field, a man who has been at the forefront of cell cycle, cell
proliferation, and apoptosis research since before he joined
New York Medical College in 1990. In addition to directing
the Brander Cancer Research Institute (BCRI), he also holds
professorships in the departments of pathology, medicine,
and microbiology and immunology. His research, which has
earned him international repute, has been supported by grants
from the NIH and the National Cancer Institute, including a
prestigious MERIT award for his research on the effects of
anticancer drugs on the cell cycle. He was also a recipient of a
grant from NASA to develop new technologies for cell staining
and analysis applicable to the micro-gravity conditions of the
Space Station. He is the holder of eight U.S. patents, author
or editor of 15 books, and has published nearly 700 peerreviewed articles.
COLLEAGUES IN CYTOMETRY
Frank Traganos, Ph.D., professor of experimental pathology
and of medicine and associate director of BCRI, has worked
with Dr. Darzynkiewicz for more than three decades and
co-authored more than 120 papers with him. “He has made
numerous contributions to our understanding of the processes
and mechanisms underlying cell proliferation, cell death, and
cell damage by investigating processes at the single cell level,”
says Dr. Traganos. In 1992, the two collaborated with other
colleagues on a paper published in Cytometry describing the
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molecular attributes that characterize apoptotic cells in flow
cytometry. Now considered a landmark paper, it has been
cited more than 1,500 times—and Dr. Darzynkiewicz has
written a host of other papers with citations numbering in
the hundreds.
He coined the term cell necrobiology, or the biology of cell
death, and is credited with developing techniques for analyz
ing cell kinetics, tumor progression and cell senescence. He
discovered the basis for identifying a cellular resting phase
known as “quiescent” or G 0. Although his name is not quite
a household word, he is perhaps best known for developing
the TUNEL assay (TUNEL stands for terminal deoxynucleotidyl
transferase dUTP nick end labeling), which remains one of the
most widely used techniques for measuring apoptosis. But his
work goes beyond simply trying to understand cell suicide.
After earning his M.D. from the Medical University of Warsaw,
Poland, in 1960, Zbigniew Darzynkiewicz earned the equiv
alent of a Ph.D. on the basis of a thesis on the teratogenic
actions of insulin in the chicken embryo. He developed a fasci
nation with cell biology “because the analysis of molecular
mechanisms in individual cells reveals the mystery of life.” His
early work focused on developing new methods for studying
enzymes in individual cells using radioisotope-labeled enzyme
inhibitors. Two years later he accepted a position at the
Karolinska Institute in Stockholm, Sweden, which, he says,
“was the Mecca for cell biologists because of the capability to
measure DNA and RNA content in individual cells.”
ADVANCING METHODOLOGY
With the methods and equipment available at that time,
Dr. Darzynkiewicz was capable of measuring 80 cells per
day—a pittance compared to the thousands per second he
measures now. Over the years the technology, and his capa
bility, advanced with radioisotope labeling and autoradiography,
and then with flow cytometry and fluorescent probes capable
of identifying a variety of cell attributes. He expanded on each
of these approaches to explore mechanisms underlying cell
proliferation and the response of cells to anticancer drugs.
In the late 1960s it was time to head for the U.S. There he
held positions at SUNY Buffalo and the Boston Biomedical
Research Institute before moving on to positions in New York
at Memorial Sloan-Kettering Cancer Center and Cornell
University Graduate School of Medical Sciences, where he
met Dr. Traganos. “I was fascinated—not so much by the
technology as with the biological problems this technology
could help solve,” he says. In their early work together at
Sloan-Kettering, Dr. Darzynkiewicz and Dr. Traganos evalu
ated potential chemotherapeutic drugs in vitro, and their work
today is still in vitro. Dr. Traganos explains that the cell-based

work is important, because “if replicated, in vivo the findings
would have broad applicability, even though it can take a long
time to see clinical applications.”
In the 1970s and 1980s, the understanding behind fighting can
cer was to poison the malignant cells, which resulted in devas
tating side effects that made cancer a word spoken only in
hushed tones of dread. During this period, Dr. Darzynkiewicz’s
lab successfully characterized the mechanism of action of
anti-cancer drugs that were effective at lower doses, resulting
in less toxicity to the patient than most of the drugs in use at
that time. One of those drugs was mitoxantrone, which is cur
rently used in the treatment of metastatic breast cancer, acute
myeloid leukemia and non-Hodgkin’s lymphoma.
GOING WITH THE FLOW
Shortly after being named director of the Flow Cytometry Core
Facility at Sloan-Kettering he was recruited to New York Medi
cal College. Zalmen Arlin, M.D., tapped Dr. Darzynkiewicz to
head the College’s new Cancer Research Institute, founded
the summer before to enable research in the etiology, classi
fication, diagnosis and treatment of tumors. The key to this
research would be flow cytometry, which allows variability
among cancer cells to be evaluated in terms of their sensitiv
ity to anticancer drugs. “The knowledge of such variability
is essential in designing clinical treatments that may be suc
cessful in eradicating all cancer cells and thereby preventing
cancer relapse,” says Dr. Darzynkiewicz.
With flow cytometric measurements, apoptosis moved to the
forefront. When damaged, normal cells become senescent,
but tumor cells do not have the same ability to respond. Lack
ing any damage control mechanism, they die via apoptosis, a
pattern of events that is so orderly the process is often called
programmed cell death. This difference can be exploited to
increase the response to cancer treatment.
“New strategies are being developed and tested in pre-clinical
studies to enhance the susceptibility of cancer cells to radia
tion and DNA-damaging drugs by increasing their propensity
for cell suicide,” explains Dr. Darzynkiewicz. “Attempts are also
being made to force cancer cells to undergo ‘cellular senes
cence,’ which permanently halts their reproductive capability.”
His lab is also studying the mechanisms in normal, non-tumor
cells to understand resistance to DNA damage. The goal is
the same as it has been for the past three decades: to ease
the injurious side effects of radiotherapy and chemotherapy by
reducing toxicity to healthy cells.
Speaking with Dr. Darzynkiewicz, one gets the sense that new
avenues in basic research are closely intertwined rather than
disconnected areas of study. In the past his work has integrated
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The Darzynkiewicz team is well acquainted with the sophisticated technology that aids in his research. From left are Frank Traganos, Ph.D., M.D./Ph.D. student
Elise McKenna, Dr. Darzynkiewicz, Dorota Halicka, M.D., Ph.D., Jiangwei Li, Ph.D., and Jan Kunicki. Not pictured is Hong Zhao, Ph.D.

chemotherapy with apoptosis, and now it integrates cancer
biology with the process of aging.
Dr. Darzynkiewicz’s work in DNA damage also spans several
decades. He was the first to show that the genetic defect in
DNA repair in xeroderma pigmentosum can be corrected. And
in 2010 he published work on double-stranded breaks and the
carcinogenicity of tobacco smoke. His laboratory also detected
constitutive DNA damage signaling as a consequence of oxi
dative metabolism. He explains, “This oxidative DNA damage
causes DNA replication stress which, when combined with
cellular growth driven by the mTOR (mammalian target of
rapamycin) pathway, is considered to be the major cause of
aging and predisposes an individual to cancer.” In addition to
rapamycin, the diabetes medication metformin and vitamin D
are potential agents for suppressing the mTOR pathway. This
suppression could create leaner and healthier cells, a context
of aging currently being studied in Dr. Darzynkiewicz’s lab.
SETTING THE STANDARD
Without flow cytometry and similar techniques “the work
Dr. Darzynkiewicz does would be decades behind,” says
Dr. Traganos. His colleague agrees. “Without these tools, our
research would be impossible,” Dr. Darzynkiewicz admits.
His current work, supported by a grant from the NIH, aims to
develop probes to study the DNA damage response and
aging processes. He is already credited with developing
probes identifying individual stages of the cell cycle to

determine the mechanism of anti-cancer drugs. And many
probes used worldwide for detecting different stages of cell
differentiation were developed by his lab, including acridine
orange and BrdU incorporation into nucleic acids. “We are one
step ahead because we’ve been developing the technology,”
he says.
The probes used in cytometry can include different molecules,
such as fluorescence-tagged antibodies or stains. The anti
bodies used as probes can be specific for cell surface pro
teins or indirectly labeled by a secondary antibody. Regardless
of the type of probe, they are important in a variety of research
areas and have a greater impact over time as more about the
role of a particular protein in the cell is understood. Dr.
Darzynkiewicz’s lab includes a cell sorter as well as a four-laser
scanning cytometer, both with multiple channels for detecting
different types of fluorescence.
In terms of sheer lab output, Dr. Darzynkiewicz ranks at the
top of the fields of cell cycle, flow cytometry and apoptosis.
He explains that his accomplishments in different areas of cell
biology are due to the development of new methods for prob
ing individual cells at the molecular level. With these methods
cell growth, proliferation, carcinogenesis and response to anti
tumor treatments can be studied.
And in this, his thirty-third year of continuous funding,
Zbigniew Darzynkiewicz, M.D., Ph.D., continues to probe
cells for answers. ■
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Pieces of the
Cardiovascular Puzzle
An Huang, M.D., Ph.D., studies estrogen, blood flow and blood
pressure, and how they fit together.
By Cynthia A. Read

A

re you among the one percent?
The question is not about what
you may think it is. It refers to
the percentage of Americans who enjoy
ideal cardiovascular health, according to
a position paper released by the American
Heart Association last March. The figure
is actually less than one percent.

Heart disease is still the leading cause of
death—not only in the U.S., but in every
major developed country. The myth that
it is primarily a man’s problem has also
been debunked. In fact, more women’s
lives are claimed by cardiovascular dis
ease than by cancer, chronic respiratory
disease, Alzheimer’s disease, and acci
dents combined. When factoring in
deaths from stroke, diabetes and other
diseases that are related to problems
with blood flow and blood pressure, the

need for better understanding becomes
even more critical.
An Huang, M.D., Ph.D., associate profes
sor in the Department of Physiology, is
studying one aspect of this challenge:
the gender-specific regulation of endo
thelial function in arterioles, the tiny
blood vessels that branch out from arter
ies throughout the body. Her research,
supported by a series of grants from the
National Institutes of Health, is part of
a multi-faceted, multi-department pro
gram at the College that pairs basic sci
ence and clinical research in a quest to
improve the outcomes in diseases that
affect the heart and circulatory system.
FROM CHINA TO NEW YORK
The youngest of four children, An Huang
grew up in the People’s Republic of
China. Both of her parents were medical

professors, so her interest in medicine
developed early. But her path was tem
porarily derailed by the harsh reforms of
the Chinese Cultural Revolution. At the
time she graduated from high school,
many students were being forced out of
cities and effectively exiled to work in
factories or farms, rather than going to
college. In 1977, after these policies
changed, Huang was among the first
group of students allowed to enter college.
She received her M.D. from Shanghai
Second Medical University in 1982 and
was directed by the government to enter
the practice of general surgery.
By the time China began to open to the
outside world in 1990, Dr. Huang had
earned an M.S. and a Ph.D. in surgery.
Feeling that she’d advanced in her pro
fession as far as she could in her home
country, she was eager to see what she

C H I R O N I A N

might learn elsewhere. Although she was
still thinking about pursuing her clinical
interests, she landed a position as a
research fellow in the Department of
Physiology in 1992. And, in what she
calls “one of the luckiest moments in my
life,” she met the late Gabor Kaley, Ph.D.,
who served for 37 years as chairman
of the Department of Physiology. “He
taught me everything about research,”
she says. “It was my great honor to be
able to work with Dr. Kaley. It would have
been impossible for me to become an
established scientist without him.”
The College brought Dr. Huang an addi
tional gift: Dong Sun, M.D., who was
also a product of the first wave after the
Cultural Revolution, was then a Ph.D.
student under Dr. Kaley. The two came
halfway around the globe to meet on the
Valhalla campus, and married in 1994.

After their daughter Angela was born in
1996, Dr. Huang brought her to work
in her bassinet when she was only a
month old so the family research proj
ects could continue.
GENDER DIFFERENCES
Beginning with her first research projects
with Drs. Kaley and Sun, along with Akos
Koller, M.D., Ph.D., professor of physiol
ogy, Dr. Huang has investigated microcir
culation—the term for the small blood
vessels embedded in organs that are
responsible for the distribution of blood
within the organ tissues and for maintain
ing blood pressure. The arterioles carry
blood to the capillaries and, like all blood
vessels, are lined with a thin layer of cells
comprising the endothelium. Among the
many functions of endothelial cells are
controlling the dilation and constriction
of the arterioles.
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Hypertension from overly constricted
blood vessels increases the workload
on the heart, leading to thickening of the
heart muscle (myocardial hypertrophy),
often followed by heart failure. Women
have a bigger vasodilator response than
men and, before menopause, a lower
risk of heart disease. It appears that estro
gen is responsible. When the ovaries
are removed from experimental animals
such as rats, the females have a reduced
dilator response, but if the same females
are given estrogen after ovariectomy, the
dilator response returns.
In their initial studies, Dr. Huang and her
collaborators explored the mechanisms
of nitric oxide (NO) in dilating arterioles in
rats and mice. When synthesized in the
endothelium of blood vessels, nitric oxide
is also called endothelium-derived relax
ing factor, so named for its ability, when
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“All the
expertise I
need is here
at NYMC.”
released from the endothelium, to signal
the surrounding smooth muscle to relax.
This dilates the vessel and increases
blood flow, therefore decreasing blood
pressure. The team showed that estro
gen increases the expression and activity
of eNOS, the enzyme that synthesizes NO.
Genetically modified mice that lack the
gene to produce eNOS, and therefore
lack nitric oxide, are hypertensive—yet
still, female mice have better regulation of
blood pressure than males do.
So Dr. Huang’s next step was to study
how estrogen affects the dilation of
blood vessels independent of the activity
of nitric oxide. She discovered additional
endothelial mediators were dependent
on cytochrome P450 (CYP). She has
also learned that different forms of CYP
are responsible for the release of other
vasodilators in rats, mice and humans.
Because this sequence seems specific
to females, Dr. Huang has begun to
explore why these gender difference

Assisting Dr. Huang in her study of gender-specific regulation of endothelial function in arterioles are, from
left: Dong Sun, M.D., Ph.D., Hongyan Wu, technician, and Caroline Ojaimi, Ph.D.

exists, which genes are involved, what
earlier influences come into play, and
how changes in vasodilation, and there
fore in the regulation of blood pressure,
are related to aging associated with
menopause.
“All the expertise I need is here at
NYMC,” she says. She continues to col
laborate with her husband and with
co-investigator Caroline Ojaimi, Ph.D.,
assistant professor of physiology. She
also receives support from Edward J.
Messina, Ph.D. ’73, professor, and
Thomas Hintze, Ph.D. ’80, professor and
chairman of the Department of Physiology,
as well as other members of the depart
ment. Dr. Messina says, “It has been a
pleasure and an honor to watch the
growth of Dr. Huang as an independent
investigator. I am impressed with her
research success, which has offered
important clues to our understanding
as to why premenopausal women are

somewhat protected from cardiovascu
lar events. She has also provided signifi
cant evidence on the relevancy of the
microcirculation in vascular biology and
medicine.”
LOOKING AHEAD
Dr. Huang thinks that better understand
ing the mechanisms by which estrogen
regulates the dilation of blood vessels
could lead to improved treatment for
menopausal women, and her research
could point to a new therapeutic target
to improve cardiovascular function where
NO is deficient.
That is down the road, however. For
now, Dr. Huang relies on a motto of
sorts: “Be solid at every step,” she says,
“keep going, and never give up.” It has
served her well, not only in her years of
research at New York Medical College
but in the life journey that brought her
more than 7,000 miles from Shanghai
to Valhalla. ■
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1: D
 rs. Alan Kadish, Karl Adler, Edward Halperin,
Francis Belloni, Ralph O’Connell and Robert Amler,
and Mr. David Raab.

3: Trustee Ronald F. Poe, President Alan Kadish, M.D.,
Honoree Karl P. Adler, M.D., and Board Chairman
Dr. Mark Hasten.

2: C
 hancellor and CEO Edward C. Halperin, M.D., M.A.,
gives the Commencement address.

4: Graduates from the Graduate School of Basic
Medical Sciences.
5: Drs. Kadish, Hasten and Halperin.

6: Dr. Halperin with Rabbi Moshe Krupka.
7: Mace Bearer, Fredrick Z. Bierman, M.D.
8: School of Medicine graduates capture the excitement
in Carnegie Hall.
9: Graduates from the School of Health Sciences
and Practice.
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Music
and
Medicine
Making a Menu for Life with

}

}

Stephen E. Moshman, M.D.,
gives equal time to his main passions.
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By Marjorie Roberts

T

he Department of Medicine is a challenging and
exceptional place to work. Many members of the fac
ulty were recruited to the Valhalla campus by friends
and colleagues from their previous lives. A case in point is
Stephen E. Moshman, M.D., who radiates energy, caring and
collegiality on a daily basis—weekends included. This not only
enables him to perform an unusual variety of tasks for his job,
but also allows him to have a second life filled with music. This
spring, his dual passions for teaching and music became a
perfect storm that honored Dr. Moshman for both his roles. He
was promoted to Professor of Clinical Medicine, a title he will
cherish in recognition of his 43 years of service to medicine—10
at the College and Westchester Medical Center (WMC)—and
gratification for acknowledgement of his 30th anniversary year
as founder, composer, and conductor of the Albert Einstein
Symphony Orchestra, serving the Bronx community through
the talents of 60 mostly non-professional musicians with a
concert agenda each year.
Medicine inspires him to teach, for Moshman a sacred word
that covers everything he does for the young heroes who follow
in his path. As director of the third-year medicine clerkship, he

has mentored students who are learning to make critical
decisions that will impact how they practice medicine the rest
of their lives. “My greatest passions are medicine and music,
but I am ardent about a lot of things,” he admits, and he is
not exaggerating. The mere mention of baseball, history and
astronomy causes his eyes to light up and his voice to rise
in intensity.
You can only wonder how he is able to find the spiritual
wherewithal and physical strength to staff, rehearse and con
duct the Einstein orchestra in four concerts a year. Ask him,
and this Renaissance man replies, “I can do it because I am
a very happy man.”
BEING HAPPY
How happy is he? Enough to spar with the colleague who
recruited him from Einstein and its affiliated Montefiore Hospital:
William H. Frishman, M.D., the Barbara and William Rosenthal
Professor and Chairman of Medicine. They were both faculty
members at Einstein, where Moshman spent 30 years before
coming to the College. They take their sworn allegiance to
differing New York baseball teams as set in stone, yet their
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In both the classroom and the orchestra pit,
Stephen Moshman dictates what happens from the
moment he walks into the room.

love of the game is reason enough to sustain their friendship.
“Baseball is the only sport. I come alive when pitchers and
catchers report for spring training,” says Moshman, a former
Brooklyn Dodger fan. He is ready to take on another frus
trating year as a Met supporter, but he wouldn’t want it any
other way.
Robert G. Lerner, M.D., vice chairman of the Department of
Medicine at the College and chief of hematology at WMC,
shares Moshman’s double appreciation of teaching and music.
The Moshmans and Lerners, who have enjoyed many perfor
mances of the Einstein Orchestra, also attend Lincoln Center
events together. “I have been very impressed with everything
he’s done,” says Dr. Lerner, although it is Moshman’s work
ethic that draws Lerner’s greatest interest and admiration.
“I got to know him better when he and I began teaching
second-year students along with his brother, Eliot Moshman,
[M.D., clinical assistant professor of medicine], an internist in
White Plains who plays French horn in the orchestra.”
There is also Norma Moshman, Stephen’s wife, who is coordi
nator for the Internal Medicine Residency Program. Together
the Moshmans make up a sort of parents-by-proxy situation,
which makes it seem like there are Moshmans everywhere.
Stephen claims he never repeats a task two days in a row, but
certain responsibilities are his alone. He teaches “Foundations
of Clinical Medicine,” a mandatory course for first- and secondyear students. And there is “Harvey,” a favorite mechanism
that involves an inventive way to teach, sometimes using musi
cal sounds for emphasis.
AN APPRECIATIVE COLLEAGUE
The Harvey Cardiopulmonary Patient Simulator is a digital life
size model of a patient with lots of heart problems, which can
be dialed up at will. Cardiac pathology and proper diagnosis
are the basic skills that Harvey helps teach to third-year stu
dents, pre-internship students, interns and residents.
Among Dr. Moshman’s other purviews are the residency
program in internal medicine where he is deputy director,

the Adult Primary Care Clinic and his teaching duties in the
Pre-Internship Program, formerly called the Fifth Pathway. As to
the variety of situations in which he finds himself, Dr. Moshman
expresses his satisfaction with volunteering for unscheduled
teaching assignments by insisting that, “I have always consid
ered myself a militant non-specialist. I accept these assign
ments with enthusiasm. After all, teaching medicine is 75
percent of what I do and I absolutely relish it all.” Dr. Frishman
concurs: “We go back 40 years. Currently, every July, he and
I share the welcoming lectures for the new clerkship students
and we teach together on the wards at WMC. He is also very
active in recruiting house staff for Valhalla.”
When pre-concert time rolls around, you wouldn’t know from
his disposition that he was stressed. Norma Moshman, who
sounds as laid back as the husband she is describing, offers
this assessment:
“For the most part he is very relaxed. He doesn’t worry. He
may have trepidations about a certain passage the orchestra
is having trouble with, but in 30 years the orchestra has never
failed him.” Any changes planned for season 31? “He doesn’t
wear tails and the musicians just wear black jackets, although
at the March concert the orchestra wore what is called
Broadway Black. Stephen wore a silver tie and they all really
looked good. Now they are considering wearing Broadway
Black all the time.”
NATURAL BORN TEACHER
In both the classroom and the orchestra pit, Stephen
Moshman dictates what happens from the moment he walks
into the room. In between he gets as close as he can by
becoming an excellent teacher who, like any good performer,
makes things exciting. A slew of teaching awards attest to his
tremendous teaching talents and famous sense of humor. But
can he continue to do everything himself? With the orchestra,
this encompasses making the selections to be played (many
are his own compositions), choosing the soloists and even
writing the program notes before he rehearses the musicians
and conducts the day of the performance. He has been

C H I R O N I A N

immersed in this medical/musical arrangement all his life,
and there is one doctor/musician who has been a part of
most of it.
Etta Eskridge, M.D., Ph.D., now an assistant professor of med
icine at the College, was 22 when she met Steve Moshman.
Both had earned their undergraduate degrees at the University
of Rochester; she chose Einstein for medical school while he
selected the University of Buffalo. She found out he was
looking for musicians for a new orchestra he was assembling
and she played the viola, a rare commodity in terms of slots to
be filled. The rest, since 1982 and then some, is history. Four
years ago Dr. Moshman recruited her to join Westchester
Medical Center, where she is a hospitalist and director of
palliative care.
“He is like a savant,” she says of Moshman. “He is a walking
encyclopedia of knowledge, and he writes the best program
notes ever…He has given all of us an unbelievable gift—the
opportunity to play music—and we do a pretty good job.” This

  

: :

New York Medical College

: :

13

past season there were six players from New York Medical
College; about one-third of the group are medical students,
faculty and house staff, and the rest are from the community.
Dr. Moshman believes his is one of the longest running com
munity orchestras in the city, and “certainly, the only medical
school-affiliated orchestra.”
Dr. Moshman has established that even in his spare time, he is
devoted to the students who are his audience—in and out of
hospital settings. Just as he learned to play the violin from his
father, his first teacher who made music such an integral part
of his upbringing, he makes himself available to those who
need help—even the ones who come around only when he
hosts his annual pool party at his Dobbs Ferry, N.Y., home
(which, by the way, was designed by a student of Frank Lloyd
Wright). The party is Dr. Moshman’s way of plying his guests
with art and the finer things in life. He has no ulterior motive for
this gesture, and no message is intended or implied—other
than to enjoy life and art, which are all around us. ■
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Is MEDICINE Ready

for Social Media?
Its proponents claim the use of new media in medicine is
a boon, causing shifting paradigms, seismic changes, and
better connections online and off.
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By Melissa F. Pheterson

T

witter, tablets, texting: these are
means and methods of social
media now surging in popularity.
They are also revolutionizing medical
practice and education, including
at New York Medical College. From
three-dimensional views of anatomy
to classroom discussions sparked by
text-messaging, the wealth of material
summoned by a few finger-taps helps
educators share and receive critical
findings, more fully engages students
with the curricula, and helps doctors
build stronger connections, online and
off, with patients.
“Why am I on social media? Because
I’m social,” says Howard Luks, M.D. ’91.
The associate professor of orthopedic
surgery at the College and chief of
sports medicine and arthroscopy at
Westchester Medical Center likes to
add, “That means sincere, open, collab
orative, interested, authentic, and like
able.” (He’ll admit the acronym is not
original, but it’s been re-tweeted many
times behind his Twitter handle, @hjluks.)
Dr. Luks writes several blogs on ortho
pedic surgery and social media, has
5,000 Twitter followers, and offers iPads
in the exam room with videos to edu
cate his patients. “Why confine my
expertise to the four walls of my prac
tice?” he asks.
For doctors and patients alike, social
media is triggering a paradigm shift in
health care. Pew Surveys show that
17 percent of mobile phone users are

using them for health care purposes,
and 44 million health apps were down
loaded in 2011. Even the prestigious
Mayo Clinic in Minnesota has started a
Center for Social Media to train physi
cians in social media strategy.
“When I first started to meet with groups
about social media in medicine, their
eyes were rolling,” recalls Dr. Luks. “They
thought it meant posting what you had
for dinner or checking in at Starbucks.
But as in all professions, the immediacy
and interactivity of social media helps
us clinicians humanize our presence
and foster our relevance in a world
that’s increasingly going online.
“They’re talking about us, talking about
health,” he declares. “Now it’s up to us
to jump into that conversation. If we
don’t control our own message, others
will define who we are.”
The College has been doing its part to
join in. In April, the annual Student Physi
cian Awareness Day (SPAD), organized
by first-year medical students, was
devoted to exploring “iMedicine: The
Role of Social Media in Medicine,” with
renowned experts convening to discuss
how social media is altering the nature
of patient care, medical education and
community outreach. The event was
well-attended, and in social media (or
SoMe) parlance, there was a great deal
of chatter and following activity that
nudged the College’s profile a bit higher
in the Twittersphere.

Among the speakers was Kent Bottles,
M.D., who serves as the social media
liaison for the Association of American
Medical Colleges. “Most older medical
educators like myself are ‘digital immi
grants’ who still speak the new language
with an accent,” says Dr. Bottles, a
Senior Fellow at The Thomas Jefferson
University School of Population Health
in Philadelphia. “It is the medical stu
dents who are the digital natives that
are really leading the way. I think it’s
relevant that the topic was introduced
[to NYMC] at a medical student confer
ence and not by faculty.”
TRANSFORMING MEDICINE
Resources for doctors. Smart phones
and tablets, equipped with task-specific
programs (called “apps”), make a wealth
of clinical information and references
readily available on a portable screen.
Among College faculty, popular apps
include Epocrates RX, a mobile drug
reference database, Medscape, a medi
cal reference guide, and Diagnosaurus,
a database of diseases and symptoms.
Resources for patients. Social media
is changing the doctor-patient dynamic:
how doctors reach out and what kinds
of information patients bring into the
office or hospital. Apps can help doc
tors engage with their patients by dem
onstrating procedures using 3-D views
of anatomy, displaying test results, and
sending text message reminders of
appointments and vaccinations. In
between office visits, doctors and
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patients can communicate directly via text or Twitter messages, or even brief video
messages, the form preferred by more than half of the patients Dr. Luks surveyed.
“Email,” he says, “is passé.”
Telemedicine, the concept of caring for patients remotely, is also gaining ground.
Dr. Bottles cites research predicting that by 2016, three million patients will be moni
tored via their smartphones, rather than in hospitals, for chronic conditions like heart
disease and diabetes.

Photo by Susan Woog Wagner

Social media can empower the patient without imperiling the doctor, stresses
Dr. Bottles. “Some patients want to record their interactions during office visits, but
many physicians are reluctant to embrace social media because of fears of malprac
tice suits,” he says. “And yet, studies have shown that patients retain only 50 percent
of what the doctor tells them during an office visit, and half of what the patient does
remember is remembered incorrectly.”
So instead of fearing the patient who comes in with reams of information printed from
the Internet, doctors can seize the chance to guide patients as they search for repu
table articles, e-mail information after appointments, or maintain a blog or website
with concise answers to common questions. Says Dr. Luks: “Some doctors will shy
away from a patient coming in with material they’ve Googled, whereas I’m turning on
the iPad, hitting Google, saying ‘There are 600 articles on medicine published every
day; let’s see if anything was posted today that’s pertinent to your case.’”
Resources for both. Increasing numbers of clinicians and researchers have now
launched Twitter accounts, whereby they can issue brief messages called tweets to
a group of followers, comprising doctors and patients alike. Tweets might include
links to new medical findings, spotlight topics posted by other experts, or offer
advice on medical issues or healthy living. More than 1,300 physicians have now
registered their Twitter feeds on twitterdoctors.net, and communities are emerging
online among doctors (Doximity.com, a social networking site for physicians) and
patients (PatientsLikeMe.com, a forum for people with similar health conditions to
support and advise each other).
BEYOND THE CLASSROOM
One morning before class, Daniel Peters, M.D., F.A.C.S., assistant professor of cell
biology and anatomy, noticed his students deeply absorbed in their phones. “It was
clear that almost everyone was texting away furiously, trying to get out that last mes
sage before class started,” Peters says. He also noted these same students hadn’t
yet responded to emails he’d sent a few days earlier. “I realized that email was obso
lete to them: in their world, it served no purpose and it was too slow and inefficient
for real-time needs.” But a text or tweet would pop up instantly on their phones,
compelling them to respond. As an experiment, Peters began to send messages to
the class via Twitter, posing questions and offering points for reflection to spur critical
thinking and discussion among his students.
“Twitter allowed me to put ideas in their heads outside of class, when they might be
together in some social situation, and use the opportunity to have an open and free
discussion,” he says. “I was also trying to show that they always had to be think
ing—the thought process does not, and should not, stop as soon as class is out.”
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43.7%
40.2%

IN A FACULTY SURVEY, 85 RESPONDENTS WERE ASKED:

Which social media platform do
you use: Facebook, Twitter,
LinkedIn, YouTube or Google+?

Among students, the study groups
known as “journal clubs” now benefit
from instant access to groundbreaking
news in medicine, with Twitter alerts
outpacing the snail’s-paced peer-review
model that produces journals.
“Physicians and researchers in far-flung
locations can discuss articles and
exchange knowledge instantly,” says
first-year medical student Neil Shah,
chair of the committee that organized
SPAD. “The flow of information is the
biggest way social media has helped
improve academic medicine.”
For institutions like New York Medical
College, social networking sites also
provide an opportunity to reach out to
prospective students, current students
and alumni. The Office of Public Rela
tions, responsible for the College’s offi
cial social media presence, is now
encouraging other departments and
groups to establish their own presence
in social media, using guidelines posted
on the College’s website.
“Curating and sharing information with
an audience of followers on social
media is a way to engage people, and
get them talking with us about some
thing that is of interest to them,” says
Donna Moriarty, M.P.H. ’04, associate
vice president of communications, who

34.5%

33.3%

10.3%

posts Twitter and Facebook updates on
behalf of the College several times per
week. “The institution becomes more
real to them, more personal, through
social media activity. It’s a way to
spread news to our students and
employees about what is happening
here, and offers a window for prospec
tive students, parents and alumni to
peer through and see what we’re up to.”

American Medical Association has
released social media guidelines sug
gesting that doctors use the maximum
privacy settings for each mode of online
communication, and consider using
separate profiles for personal and pro
fessional use. Many hospitals and prac
tices now raise the issue with patients
as soon as they check in, presenting a
contract with waivers or disclaimers.

RED FLAGS
In the uncharted waters of social media,
new ethical and legal dilemmas can
pose unexpected hazards. Should doc
tors or professors initiate and accept
“friend” requests from patients or stu
dents? What if a patient solicits medical
advice online that ends up flawed?
What if a medical student or resident
posts descriptive comments of a clinical
experience, inadvertently violating HIPAA
rules governing patient privacy? These
issues are a “major concern,” says Shah,
but doctors, professors and institutions
can protect themselves by educating
students and patients about the perils
of social media. “Anyone using social
media,” says Kent Bottles, “needs to
think about the permanent and public
nature of anything on Twitter and
Facebook.” Howard Luks emphasizes
that he doesn’t treat patients via social
media, only shares information. The

“Once I learned about social media, I
realized the user has controls,” says
Anthony Sozzo, M.A., M.S.Ed., associ
ate dean for student affairs, who main
tains a popular page on student financial
planning, and who has produced pod
casts and YouTube video clips for, and
with, the students. “You can still main
tain a professional presence on social
media.” That synthesis of clinical excel
lence and social media was among the
major objectives at SPAD, with a live
Twitter feed enhancing discussion and
debate even further.
"Because of SPAD, the College will gain
a significant amount of attention, kudos
and support,” says Dr. Luks. If it means
dissolving the barriers to communica
tion, then New York Medical College
has added a few more instruments to
its black bag. ■
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BEYOND

SKIN
DEEP
In learning to treat the
skin—the mirror of
internal diseases—
dermatology residents
inject dermatologic
care into a host of
other specialties.
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experiences she and the other residents gain from treating
patients, says Jodi Langer, M.D., who serves as co-chief resi
dent with William Rietkerk, M.D.
MANY CALLED, FEW CHOSEN
Considered among the nation’s best, the New York Medical
College dermatology residency program is very competitive.
From more than 300 applicants, just three are chosen annu
ally. To be selected, says Dr. Safai, a resident “must have an
intelligent mind and be able to quickly retrieve and grasp a lot
of information.” She or he also must be a clear thinker, a good
writer and an effective “people person.” Finally, says Dr. Safai,
residents must be able to learn independently and be good
team players.

By Nelly Edmondson Gupta

I

n 1993, Bijan Safai, M.D., professor of dermatology, took
over as chairman of the Department of Dermatology at
New York Medical College in Valhalla. Several years later,
he moved the residency program from Westchester to upper
Manhattan’s Metropolitan Hospital Center, a public hospital
and College affiliate that treats many underserved patients.
This move turned out to be a boon for both the residency
program and the patient population it serves.
“I brought the residency to the patients,” says Dr. Safai. By
that he means that taking care of a more diverse, inner city
population gives the future dermatologists under his tutelage
an opportunity to treat the full spectrum of clinical diseases.
The residents care for everything from acne to leprosy to toxic
epidermal necrolysis (TEN), a potentially deadly skin disease
that usually results from a drug reaction.

There are other benefits as well. “One of the great things about
working at Metropolitan Hospital is that we see patients from
varied ethnicities,” says first-year resident Lavanya Krishnan,
M.D., one of 10 residents currently enrolled in the Collegesponsored program. Many skin diseases, she explains, pre
sent very distinctively in different types of skin. For example,
rashes that appear on deeply pigmented skin tend to be more
subtle or textured. If a doctor isn’t well-versed in these skin
differences, making an accurate diagnosis can be especially
challenging.
Residents’ learning touches on the entire spectrum of medical
dermatology, including immunologic diseases of the skin,
cutaneous lymphomas and sarcomas, drug eruptions, genetic
syndromes affecting the skin, and dermatologic emergencies.
They also learn how to perform laser surgery, Mohs micro
graphic surgery, blepharoplasty and skin cancer removal. In
short, they learn it all. “We could write a textbook” with the

In fact, the competition for dermatology residency slots has
become increasingly stiff nationwide. “When I took over, resi
dents were mostly selected from the New York area,” says
Dr. Safai. “Now we get the best applicants from all over
the country.”
In addition to working with a wide variety of interesting patients,
one of the best things about the NYMC program, say the resi
dents, is the solid grounding in both clinical work and pathology.
“One of the things that initially attracted me to NYMC was this
clinical-pathologic correlation,” says first-year resident James
Highsmith, M.D. In other programs, he explains, residents may
learn to read pathology slides, but not necessarily the slides
they themselves have prepared from biopsies. “It’s nice to see
the clinical picture—your patients—and then review their biopsy
slides under the microscope,” says Dr. Highsmith. “It really
helps you learn and remember.”
TEACHER, TEACH THYSELF
Yet another draw for the NYMC program is the fact that all
dermatology residents have plenty of opportunities to teach
as well as learn. Each week the residents complete multiple
academic duties, including journal reviews of medical and sur
gical dermatology, Kodachrome sessions (clinical slides used
for diagnostic practice), pathology training and book review
lectures. The residents take turns delivering lectures to their
peers on topics in the main textbook. In order to answer ques
tions and provide background and context, the designated
lecturer must go beyond the text, thereby deepening his or
her knowledge base.
The dermatology residents also teach medical students and
give lectures to other departments. “Medical students have a
limited exposure to dermatologic disease during med school,
but many other specialties, such as internal medicine and
pediatrics, need significant knowledge about the skin,” explains
Richard McCarrick, M.D., vice dean for graduate medical
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Dermatology director and department
chair Bijan Safai, M.D., above, says
the highly competitive program at
New York Medical College admits
only three new residents per year.
Residents Lavanya Krishnan, M.D.,
and William Rietkerk, M.D., prepare
to treat a patient at Metropolitan
Hospital Center.

education and affiliations. “So they rely on the dermatology
residents to build their knowledge of skin diseases.”
Although relatively few patients are admitted to hospitals solely
because of skin conditions, they may have skin problems in tan
dem with other disorders. For example, a psychiatric patient may
be admitted in crisis, and a subsequent physical exam reveals a
rash or severe lesions on his lower back. Having dermatology
residents available for consult enables the psychiatric team to
provide comprehensive care. “There is a tremendous benefit
to having a derm residency in a hospital that goes far beyond
treating patients who present with primary skin problems,” says
Dr. McCarrick. “Throughout the hospital, having derm residents
and attendings is clinically and educationally very helpful.”
The residents truly must learn to master the art of diagnosis in
order to recognize underlying systemic conditions. In fact, the
residents and their supervising attending physicians provide der
matologic consultation for all inpatient services and ambulatory
care programs. They have to know the basics of internal medi
cine, pediatrics, neurology, surgery and psychiatry to be able to
competently integrate dermatologic care into all of these fields.
IT’S NATIONAL AND PERSONAL
Indeed, dermatology has been getting more respect from all
quarters lately, and is now the most competitive specialty. In
recent years, many American medical school graduates have

been migrating away from primary care and general surgery. As
a recent article in The New York Times noted, dermatology—like
plastic surgery and otolaryngology—provides relatively controlla
ble hours, autonomy, and improved quality of life, and has the
added benefit of being the kind of doctor patients actually like
and want to visit.
Second-year resident Kathryn Russell, M.D., says that while she
was growing up in Sarasota, Fla., her dermatologist “was the
only doctor I enjoyed going to.” Every year, her mother took
fair-skinned, redheaded Kathryn to a dermatologist for a fullbody skin exam; the Russells have a family history of skin can
cer and Kathryn is at increased risk. Instead of dreading these
medical visits, she actually looked forward to learning about
her skin, hair and nails during her examinations. Dermatology
“is a very fulfilling field because patients really appreciate you,”
she says. “You treat them, and they look better—and feel bet
ter about themselves.”
HAVING SKIN IN THE GAME
“There’s a whole list of reasons to go into dermatology,” says
second-year resident Robert Lott, M.D. He points out that
research in the field of cutaneous immunology and molecular
biology of skin is moving at a rapid pace. “As a result, we are
developing a better understanding of the immunologic and
molecular pathogenesis of skin disease leading to optimized
diagnosis, management and treatment of patients,” he says.

C H I R O N I A N

These new developments are helping researchers create
“designer drugs” for the treatment of skin-related autoimmune
diseases, like psoriasis. “Many systems collide in the skin,”
notes co-chief resident Langer. “The skin is a mirror of internal
diseases, with sequelae from immunologic, neurologic, infec
tious, endocrine and neoplastic processes.” This “collision”
is evident in many systemic diseases, such as lupus, some
cancers, hypercholesterolemia and liver disease, which often
show up first on the skin. In other words, adds Dr. Langer,
“The research we’re doing on skin may have greater applica
tions beyond the skin.”
Each year, every NYMC dermatology resident must undertake
an intensive research project. This year, they are studying
a broad array of topics, including polymorphisms of nonmelanoma skin cancers, skin stem cells, which can be
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used for growing hair and curing some of the blistering dis
eases of childhood, and skin manifestations of graft vs. host
disease, a serious condition that can develop after bone
marrow transplantation.
“Dermatology is a rapidly evolving field, and cutting-edge in
terms of new technology,” adds Dr. McCarrick. “Dermatologists
are in great demand, and there’s a shortage in many parts of
the country.”
Drs. McCarrick and Safai believe this group of residents will
become experts and leaders in the field. Every year, says
Dr. Safai, he continues to be pleasantly surprised. “Our der
matology residents are committed and diligent, and they are
here to learn. They study hard, help each other and work well
as a team.” ■

Residents gather weekly for peer-teaching sessions. Clockwise from the presenter, Pantea Hashemi, M.D., are Jodi Langer, M.D.; David Weinstein, M.D.; Jennifer
Leininger, M.D.; Lavanya Krishnan, M.D.; Robert Lott, M.D.; William Rietkerk, M.D.; Jennifer Vickers, M.D.; Kathryn Russell, M.D.; and Bijan Safai, M.D., professor
and chairman. Not pictured is resident James Highsmith, M.D.

• A REAL HONOR

In February, Dr. Safai was elected president of the Physician Affiliate Group of New York (PAGNY), made up of more than 2,500 physicians
and health care professionals who provide services to the half dozen hospitals that comprise the New York City Health and Hospitals
Corporation (HHC), the largest public health system in the U.S. “It is quite an honor for me to be trusted by my colleagues and elected as
president of such an important organization,” Dr. Safai says.
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John Nunez,
Izuchukwu Ibe
and Andrea Love:

Student Athletes
Compete to Stay
Mentally and
Physically Fit

John
Nun
ez

By Andrea Kott, M.P.H.

T

he biggest disconnect in pre
paring for a career in the health
sciences may be how unhealthy
the journey can be. Too little sleep, too
much fast food and not enough exercise
are the pillars of life for medical students
and graduate students. That is, unless
they are so committed to fitness that
their success depends on it.

John Nunez, Izuchukwu Ibe and Andrea
Love are such fitness-philes. They don’t
jog or take the occasional Zumba class.
They train for marathons, compete in
semi-pro soccer tournaments and prac
tice black belt judo. They would no
more miss a workout than they would
cut a class, clinic or lab.

JOHN NUNEZ, SOCCER
School of Health Sciences and
Practice
As John Nunez tells it, two things saved
him during his first semester as a doc
toral candidate in physical therapy: the
camaraderie of classmates and playing
semi-pro soccer. “It was the hardest
academic semester of my life,” the
second-year PT student says, recalling
a schedule that included neuroscience,
physiology and exercise science. Then,
two months before school started, he
was invited to try out for the Cosmo
politan League—the Cadillac of amateur
soccer leagues. It was a fantasy come
true for the lifelong soccer player, who
had always dreamed of playing collegelevel soccer (he played Division 1 at
College of the Holy Cross) or going
into medicine.

“I’m playing at a higher level than I ever
thought I’d play,” says Nunez, who now
competes among world class players.
His level of commitment might seem
incompatible with doctoral studies.
Indeed, Nunez says some classmates
scratch their heads when he closes his
books and leaves for practice. Yet for
this 27-year-old, who is both exuberant
and calm, there is no choice. In the first
place, playing soccer keeps him aca
demically focused. “It keeps you on top
of your school work,” he says. Second,
being fit is critical for physical therapists,
who often must lift patients heavier than
themselves and are uniquely positioned
to inspire patients toward greater levels
of health. “As a medical professional,
you should demonstrate fitness and
good health to patients,” Nunez says.
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“If we’re going to tell patients to be
healthy, then we have to be healthy,”
he says. “Just saying you can’t do it
isn’t a reason not to do it.”

Izuchuk

wu Ibe

Nunez has always been fascinated by
the human body and its capacity for
endurance. Although he once envisioned
following in the footsteps of his orthope
dist father, his own athleticism sparked
his interest in the more hands-on, pre
ventive approach of physical therapy.
“Once you get injured a few times and
undergo PT, you realize how you can
use your knowledge to be safe and
prevent injuries,” he says. Conversely,
Nunez the athlete is always thinking

about pushing physical limits. “As a
physical therapist, you always wonder
if a patient is at risk. How far can they
push themselves?”
Nunez lives to push himself. Twice a
week at 9 p.m., after eight hours of
school, he drives to Queens to prac
tice with his team, the New York Greek
Americans. The exhaustive workout
includes more than two hours of fast
runs, sprints and interval training, drills
tailored to build lung endurance and
the body’s ability to recover quickly.
“It’s about [seeking] the maximum
of what your body can do,” he says.
He plays two games on weekends,
although he tries not to compete when
his schedule includes clinical rotations,
because an injury could prevent him
from performing necessary physical
tasks. Throughout the year, Nunez
keeps up with training and practices,
picking up games with indoor soccer
leagues at home in Fishkill, N.Y., playing
club soccer with other students on
campus, lifting weights in the College
fitness center and training for marathons.
The regimen keeps this emerging physi
cal therapist in top physical shape, dis
ciplined and focused. Plus, it just feels
good, he says, “knowing I can do some
thing like that and still maintain the
grades.” Not that he would have it any
other way. “As an athlete, excuses don’t
exist for you.”

IZUCHUKWU IBE, RUNNING
School of Medicine
Excuses don’t exist for Izuchukwu Ibe
either, although the second-year medical
student admits his runner’s discipline
developed only recently. “The mental
part of pushing myself was there, but
not in running,” says the Nigerian native,
who played soccer for SUNY Albany,
where he entered as a freshman at age
16. “I always told myself, ‘Running is
boring, I’m never going to run past six
miles.’” But last summer, just one month
into his first year of medical school, the
22-year-old traded his soccer cleats for
running shoes to train for the New York
City Marathon. Along the way, he dis
covered he was capable of more than
he ever knew.
Ibe had never run more than three or
four miles a couple of times a week
to stay in shape. Then he met Debra
Gerson, M.D., medical director of the
Open Door Family Medical Center, a
College affiliated clinic. Dr. Gerson was
his supervisor during a summer program
that exposed high school students to
the medical field. A cancer survivor, she
described the thrill of running her first
marathon. Her feat inspired him to give
it a try.
At the beginning of his second year,
with only three months to train and a
mandate to raise at least $2,000 for a
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sponsoring charity, Ibe harnessed his
medical student’s mettle. He started
running three to five days a week, and
lengthened each run by one- to threemile increments. Fortunately, his work
outs provided a valuable respite from
studying. “Training for the marathon
was my getaway from school,” he says.
But school got hectic and by marathon
day, Ibe had not managed to train beyond
18 miles, the point in the actual race when
his legs almost buckled. That’s when he
noticed other runners. “I saw a runner
with one leg, racers in wheelchairs, run
ners who were overweight, skinny, young
and old,” he says. They inspired him.
Four hours and 38 minutes later, Ibe
finished the race. He also raised $3,000
for Shoe4Africa, which builds children’s
hospitals in Kenya. “I crossed the finish
line and I thought, ‘I’m signing up for
another one.’”
As other runners have inspired Ibe, who
is set on practicing orthopedics, so does
he hope to inspire patients. “If we’re
going to tell patients to be healthy, then
we have to be healthy,” he says. “I said,
‘I can’t run more than six miles’ and I
ran 26. I said ‘I can’t raise $2,000’ and
I raised $3,000. Just thinking you can’t
do it isn’t a reason not to do it.”
ANDREA LOVE, JUDO
Graduate School of Basic Medical
Sciences
For Ibe and Nunez, training for athletic
competition is about staying mentally
sharp, physically fit and pushing personal
limits. For judo black belt Andrea Love,
a Ph.D. candidate in the Department of
Microbiology and Immunology, it is also
about increasing productivity and releas
ing stress. Working out is non-negotiable
for Love, even if it means sacrificing a lit
tle sleep. “You reach a saturation point,”
she says of the long hours she spends in
the lab. “If you take an hour-long break
to do anything, it can really get you back
on track.”

Judo puts Love back on track. Four to
five nights a week, she drives to North
Bergen, N.J., where she practices a
repertoire of skills that include throwing
opponents, pinning them down, choking
them (to unconsciousness if they don’t
forfeit the match) or twisting their elbow.
With her long dark braids, chic black
eyeglasses and a tiny stud in her nose,
Love, 24, doesn’t look like a judo cham
pion, let alone a nationally certified coach
with the U.S. Judo Association. She
clearly gets a kick out of that. “Dude, I
fight people,” she says, displaying her
unmanicured nails. “If I leave practice
and I don’t have any bruises, I feel like
I didn’t work out hard enough.”
Growing up in Norwich, Conn., Love
started studying judo at age 4. “I hated
ballet,” she recalls. “I was a tomboy—
always in the woods, building tree houses,
collecting bugs. I was a feisty little kid,”
she says. She started competing at 5,
was a nationally ranked champion by 15
and a black belt one year later. Although
injuries kept her off the competition cir
cuit during her undergraduate years at
SUNY Stony Brook, she is preparing to
return. This means her days in the lab,
where she studies the immune response
to infection with Borrelia burgdorferi, the
bacterium that causes Lyme disease, are
especially long. But she doesn’t miss a
workout, which typically includes running

“I was a tomboy,
always in the
woods, building
tree houses, collecting bugs. I
was a feisty little
kid,” she says.
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(she has run marathons and half-mara
thons), strength training and practicing
on the judo mat. If she can leave midexperiment to work out, she will, some
times returning to the lab as late as 11
p.m. to finish. “When you’ve been work
ing on an experiment for two months
and it fails, it’s really nice to beat up on
somebody,” she kids. “It definitely helps
my mood and productivity.”
After she graduates in two years, Love
hopes to work in the field of infectious
disease for the Centers for Disease
Control or the National Institutes of
Health. Wherever she lands, she says
she will keep practicing judo. “It’s an
awesome full body workout and incredi
ble stress relief.” ■
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Investigating
Epilepsy: Calming the
Electrical Storm
By Chirag Upreti

E

pilepsy is a debilitating neurological disorder that affects
about one percent of the world’s population. In the brain,
neurons communicate with one other at specialized junc
tions called synapses. Electrical signals that travel down the
presynaptic neurons release a chemical messenger, or neu
rotransmitter, which then diffuses and activates its receptors
on the post-synaptic neurons, leading to the generation of

Explain It All

electrical signals in the postsynaptic neurons, thus success
fully transferring the electrical information from one neuron to
the other. The presynaptic mechanisms that may be altered in
epilepsy remain poorly understood, though research from our
lab suggests that epilepsy leads to both structural and func
tional alterations. My current research examines prospective
changes in these synaptic compartments, and whether they
could serve as therapeutic targets for novel drugs.
The most common drug-resistant form of epilepsy is called
mesial temporal lobe epilepsy (MTLE). My research has
focused on the hippocampus, a part of the brain that can be
severely damaged by MTLE. A few very limited studies have
examined the functional properties of how neuronal properties
are altered in epilepsy. In particular, I was interested in how the
neurons may alter the secretion of the neurotransmitter in epi
lepsy, by altering the recycling of the packets or vesicles into
which they are packed. In the laboratory of Patric K. Stanton,
Ph.D., professor of cell biology and anatomy and of neurology,
the tools and the expertise—along with animal models that
can robustly recapitulate the human disease—allowed me to
focus on a precise question: Do the vesicles that contain the
neurotransmitter recycle in a manner different than under nor
mal circumstances?
Using live cell imaging and 2-photon microscopy of these subcellular compartments called presynaptic terminals, we were
able to demonstrate that the acute brain slices derived from
epileptic animals showed greater vesicle fusion and recycling
characteristics. This suggests that regions of the brain could
secrete more of the excitatory neurotransmitter and thus lead
to hyperexcitability and hypersynchronization of neurons, likely
progressing to the epileptic state.
In collaboration with colleagues at the University of Texas (UT)
Brownsville and UT Austin, we used transmission electron
microscopy to determine persistent alterations in the ultra
structure of these presynaptic terminals. Our work suggests
that these synaptic terminals are persistently altered in struc
ture and function in the pathophysiology of epilepsy and could
also serve as therapeutic targets for novel drugs targeting
intractable epilepsy. ■

➤ CHIRAG UPRETI
Chirag Upreti has been studying the cellular and molecular mechanism of epilepsy, an interest that dates back to his witnessing a childhood friend suffer
a seizure as they played a cricket match in his hometown of Nainital, India. His fascination with neuroscience grew as an undergraduate at Osmania
University in Hyberabad, where he received a B.Sc., and at Panjab University in Chandigarh. He is a member of the American Epilepsy Society, and hopes
to further his career with postdoctoral study in the field. At press time, he had just accepted a postdoctoral position in the lab of Nobel Prize winner Eric
Kandel, M.D., at Columbia University.

C H I R O N I A N

Not All Sugars Are Created
Equal: Effects of High
Fructose Consumption
on the Heart
By Elizabeth Kertowidjojo

T

he simple monosaccharide fructose has generated a
controversy unlike any other sugar. A recent national
health and nutrition examination survey found that
Americans consume more than 10 percent of their caloric
intake in the form of fructose, with adolescents consuming
up to 15 percent.
The consumption of fructose, especially in the form of high
fructose corn syrup (HFCS) is almost impossible to avoid in
commercial food products. Parallel to the rise in fructose con
sumption is an increase in obesity and the development of
metabolic syndrome, a constellation of signs and symptoms
including elevated plasma glucose, hypertension, dyslipidemia,
insulin resistance, and central obesity. Studies have found a
causal relationship between high fructose consumption and
these conditions, although the mechanism behind this rela
tionship remains unclear.
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My work centers around the effects of high fructose consump
tion on the cardiovascular system. Metabolic syndrome
increases the risk of cardiovascular mortality more than threefold, and many of the harmful effects of fructose, such as
hypertension, atherosclerosis and endothelial dysregulation,
are directly related to metabolic syndrome. A link that is often
found between lifestyle factors and cardiovascular dysfunction
is inflammation and oxidative stress, specifically an elevated
superoxide level. Superoxide is a free radical generated by a
one-electron reduction of oxygen, and is mainly produced as
an essential part of the immune process of pathogen killing.
Elevated superoxide is often found in patients with detrimental
lifestyle factors, such as smoking.
Among the harmful effects of superoxide is the scavenging
of nitric oxide (NO), a gaseous signaling molecule essential
to normal cardiovascular function. Discovered more than 20
years ago, NO is best known for its role as a vasodilator and
is still intensively investigated because of its numerous roles
in signaling events and cardiac metabolism, many of which
are essential to the cardiovascular system. We hypothesize
that the detrimental effects of high fructose consumption stem
from an increased level of superoxide, effectively reducing NO
bioavailability and negatively affecting the heart.
In accordance with the literature, our study shows the devel
opment of metabolic syndrome in fructose-fed animals, namely
hypertension, insulin resistance and hyperurecimia. Fructose
feeding alters cardiac substrate utilization and increases car
diac work. The left ventricle of fructose-fed animals also dem
onstrates an altered cellular metabolism, which is corrected
with the addition of an exogenous NO donor. Incubation with
tiron, the superoxide scavenger, or losartan, an angiotensin II
receptor blocker, had a similar rescue effect.
Overall, our results have shown that high fructose consump
tion increases the production of superoxide, lowering NO bio
activity and inducing detrimental changes in the heart. We are
currently conducting studies to further investigate the mecha
nism behind this process, specifically determining the role of
angiotensin II, a known activator of the superoxide-producing
enzyme, NADPH oxidase. ■

➤ ELIZABETH KERTOWIDJOJO
Elizabeth Kertowidjojo, originally from Jakarta, Indonesia, is an M.D./Ph.D. candidate in the laboratory of Thomas H. Hintze, Ph.D. ’80, professor and
chairman of the Department of Physiology. After earning a B.S. in biochemistry and psychology from University of California, San Diego, in 2007, she
joined NYMC as a medical student, and later the Graduate School of Basic Medical Sciences to pursue a joint M.D./Ph.D. degree. Ms. Kertowidjojo
intends to pursue both a clinical and academic career, aiming to further the field of translational science.
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Irina Ellison, Ph.D. ’05:
STAMPING OUT SMOKING AND BUILDING
COMMUNITY
By Andrea Kott, M.P.H.
If you smoke within sight of Irina Ellison, Ph.D. ’05, she will
make a point of asking you to stop. She won’t lecture, judge or
harass you. But she will take the time to explain that smoking
endangers not just a smoker’s health but also the health of
nearby nonsmokers. Not smoking around others is, therefore,
a matter of personal and social responsibility.
“There are people who roll their eyes—usually the smokers,”
Ellison says of the reactions to her crusade. “But when I get
them one-on-one they open up and realize why there’s a fault
in their logic in terms of exposure to secondhand smoke.”
Soft spoken and cheerful, Ellison does not seem audacious
enough to ask a complete stranger to put out a cigarette. She
definitely seems too mild-mannered to inform a pack of students
that they cannot smoke on the campus of St. Francis College
in Brooklyn, where she teaches cell and molecular biology. But
the 31-year-old pathologist is fearless, and has done both.
Moreover, she is determined to persuade people that personal
acts have public consequences:
that one person’s smoking can
harm the health of many.
Because of her activism, St.
Francis College became a fully
smoke-free campus in 2011.
“We are the first New York City
campus to go completely
smoke free,” she says proudly.
Unlike some anti-smoking advo
cates, Ellison’s campaign is
not a backlash against a child
hood spent choking on rela
tives’ secondhand smoke. She
has simply always been inter
ested in disease prevention. Her
dissertation research on the
ways that different racial groups
metabolize cigarette smoke—
and her finding that smoking

NEWS
puts some minorities at greater risk than whites—stoked her
interest even more. “I’m interested in bridging basic science
research with public health research to help people understand
how their behaviors affect their health,” she says.
To hear Ellison make her case against smoking is to understand
how one person can convince an entire community to make
public health a top priority. “Smoking is the number-one cause
of preventable disease in the world,” she says, revving up to
recite a litany of smoking-related facts. “Cigarette smoke affects
fertility and sexual performance. It is a huge source of free radi
cals and air pollution. And cigarette butts are the most littered
item in the world.” She lets the information sink in, then continues:
“The number of people who die per year from secondhand
smoke is much greater than the number of people who die in
drunk-driving accidents. We have laws about drunk driving.
For some reason the message has not hit home with second
hand smoke.”
Ellison recognized the problem of secondhand smoke at St.
Francis College when she arrived in 2006 and observed smokers
congregating at the school’s only entrance and exit. “Not only
was it not a good image for the college, but it was a public health
concern for both the community and the college,” she said.
She convinced the administration to host a “Great American
Smokeout,” which encourages smokers to give up the habit
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“I’m interested in bridging
basic science research
with public health research
to help people understand
how their behaviors affect
their health,” she says.
for a day. The event, co-sponsored by the American Cancer
Society, featured workshops in hypnosis and stress reduction,
karaoke singing (to test lung capacity) and the dispensing of
free, six-week supplies of nicotine patches. The smokeout was
such a success that the college recently hosted its fifth.
With each smokeout, approximately 30 people kick the habit,
Ellison says, noting the modest but encouraging result. “It takes
the average person 7 to 10 tries to quit smoking,” she says,
clearly compassionate toward those struggling to kick the habit.
Compassion may be atypical among anti-smoking zealots, but
Ellison believes it is critical for conveying her message. She
doesn’t just tell people they should quit. She injects empathy
into a broader message about the toll that smoking takes on the
public health. “I don’t lecture that smokers should quit so much
as explain how their smoking affects other people,” she said.
“I thank people for moving away. I tell them, ‘You’re impacting
the quality of people’s lives, and if you need resources about
quitting smoking, let me know.’”
So far, a college in Virginia has contacted Ellison to ask for guid
ance in making its campus smoke-free. Meanwhile, at St. Francis,
her campaign has evolved from a lesson in public health to a
model for community building, sparking conversations about
the importance of promoting respect when opinions differ. To
Ellison, not smoking is showing respect. “I talk to my students
about it. We talk about why it’s important to respect the health
of others.”
To some, Ellison is a godsend; to others, she is a challenge.
Still, she is undaunted. “I’m about to go home and I will probably
see someone smoking and get into a 45-minute conversation
with them,” she says with a laugh. “This is my opportunity to
help somebody.” n

Alumni
Renee A. Perry, M.P.H. ’98, died
June 27, 2011. She was 64.
Richard L. Blitz, M.D. ’88,
died November 23, 2011. He was 51.
Dean H. Wasserman, M.D. ’75,
died on May 21, 2012. He was 61.
Stephen R. Bolkin, M.D. ’71,
died January 18, 2012. He was 68.
Robert C. Sabatelle, M.D. ’65,
died January 13, 2012. He was 72.
Anthony Barone, M.D. ’64,
died February 21, 2012. He was 73.
Leon I. Miller, M.D. ’64,
died January 20, 2012. He was 79.
John J. Bucchiere Jr., M.D. ’62,
died February 3, 2012. He was 75.
Howard B. Grunther, M.D. ’62,
died January 11, 2012. He was 75.
William E. Tesauro, M.D. ’62,
died November 7, 2011. He was 76.
R.P. Altman, M.D. ’61,
died July 27, 2011.
Nicholas A. Conforti, M.D. ’61,
died November 1, 2011.
Joseph F. Kennedy, M.D. ’61,
died January 24, 2012. He was 76.
William F. Flynn, M.D. ’60,
died December 9, 2011.
Henry T. Grant, M.D. ’60,
died December 17, 2011. He was 78.
Leo J. Greco, M.D. ’60,
died December 24, 2011. He was 78.
Herbert H. Joseph, M.D. ’60,
died August 1, 2011. He was 77.
Stephen T. Cogen, M.D. ’59,
died February 15, 2012. He was 79.
Donald J. Bradley, M.D. ’56,
died October 18, 2011. He was 83.
James C. Wright, M.D. ’56,
died March 22, 2012. He was 81.
Alois Kallfelz, M.D. ’55,
died February 16, 2012.
George W. Valentine, M.D. ’55,
died July 2, 2011.
Richard Fisch, M.D. ’54,
died October 23, 2011. He was 85.
Edward I. Henry, M.D. ’54,
died in December 2011. He was 82.
John E. Aiken, M.D. ’53,
died December 6, 2011. He was 87.

William P. Coats, M.D. ’53,
died March 19, 2012. He was 90.
Irving N. Rubinstein, M.D. ’53,
died August 30, 2011.
Carl J. Levinson, M.D. ’52,
died November 21, 2011.
Arthur G. Sullivan, M.D. ’52,
died December 12, 2011. He was 86.
Stanley A. Wanlass, M.D. ’52,
died in 2012. He was 89.
Charles V. Tierney, M.D. ’51,
died February 16, 2012.
Henry T. Uhrig, M.D. ’51,
died November 17, 2011. He was 89.
Richard R. Bass, M.D. ’49,
died January 12, 2012.
Eugene E. Gaudet, M.D. ’46,
died November 4, 2011.
Walter W. Kelley, M.D. ’44,
died December 10, 2011. He was 96.
Joseph M. Andronaco, M.D. ’42,
died February 11, 2012.
William Rubin, M.D. ’37,
died November 4, 2011.

Faculty
Robert Goldstein, M.D., professor
emeritus of medicine and former
associate dean for student affairs,
died on April 27, 2012 at the age of
99. Dr. Goldstein joined the College
faculty in 1961 and served as chairman of the Department of Medicine
from 1969 until 1976. Although
he retired in 1985, he continued
serving on numerous committees
until 2002. Dr. Goldstein’s true fervor was his dedication to the medical
students he served. Students dedicated the yearbook to Dr. Goldstein
five times, and in 1993 the graduating class established the Robert
Goldstein, M.D., Society of Teachers
Award to recognize exceptional and
inspiring faculty members.
Harold Michal-Smith, M.D., former
professor of pediatrics, died on
December 20, 2011.
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Milestones

ALUMNI ACHIEVEMENTS
In this section of Chironian, we publish Class Notes sent
by our readers. News items should be brief, timely—and
legible! Submit Class Notes online at www.nymc.edu/
alumupdate, or by mail to Alumni Relations, New York
Medical College, 40 Sunshine Cottage Road, Valhalla,
NY 10595. Be sure to look for us on Facebook and
Twitter (@NYMC_tweets).

00s

the

Kira Geraci-Ciardullo, M.D.,
M.P.H. ’07, was re-elected vice
speaker of the Medical Society of
the State of New York. She is also
an adjunct assistant professor of
pediatrics at NYMC.

90s

the

Hurrah’s Nest: Memoirs of a Money
Trader is the latest book written by
Barbara A. Kennedy, M.P.H. ’96.
Ms. Kennedy worked on Wall Street
for more than 20 years prior to
attending NYMC. The novel explores
the bio/psycho/social/spiritual
issues of relationships.

80s

the

Victoria T. Crescenzi, M.D. ’89,
retired from the U.S. Navy in
September 2009 after 20 years
of service. She is currently a developmental/behavioral pediatrician
at Bremerton Naval Hospital in
Washington State. She is married
to Peter C. Carlo and they have
two children.
The American Academy of Physical
Medicine and Rehabilitation (PM&R)
awarded Michael Fredericson,
M.D. ’88, the Physiatric Association
of Spine, Sports and Occupational
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Rehabilitation (PASSOR) Legacy Award
and Lectureship. Dr. Fredericson is
professor and director of PM&R
sports medicine in the Department
of Orthopedics at Stanford University
and fellowship director for Stanford
Sports Medicine.
Leona Borchert, M.D. ’87, is a
medical director for oncology medical affairs at Boehringer Ingelheim
Pharmaceuticals in Ridgefield, Conn.
As a senior medical reviewer for the
oncology division, she ensures that
all oncology information, including
television commercials that are
directed toward health care providers
and patients, is medically accurate
and meets FDA regulations.
Steven J. Litman, M.D. ’87, was
named to Castle Connolly’s top
doctors for pain management.
David Gross, M.D. ’84, his son
Joshua A. Gross, a medical student,
and two colleagues were co-authors
of a paper, “Metastatic Hepatocellular
Carcinoma to the Skin Staining Posi
tive With HMB-45,” published in the
February 2012 issue of the American
Journal of Dermatopathology.
Rebecca Steckel, M.D. ’83, reports
her oldest son is enrolled at Ramapo
College of New Jersey, her second
son is in 11th grade at Hillel Yeshiva
High School in Ocean Township, N.J.,
and her youngest daughter just
started high school there.

Susan J. Blakeney, M.S. ’92,
M.P.H. ’10:
TWO DEGREES, TWO PATHS TO MAKING
A DIFFERENCE
By Cynthia A. Read
In May, Susan Blakeney flew to New Delhi, India, to begin six
months as a Pfizer Global Health Fellow, working with Project
HOPE’s India Diabetes Educator Project. That’s a long way,
geographically and conceptually, from her education in bio
chemistry and her career as a principal research scientist in
Pfizer’s vaccine research program in Pearl River, N.Y. But, look
ing back, she describes her life as a process of stones falling
into place, one by one, all leading her to where she is now.
Blakeney has always been a questioner, eager to understand
how things work. “Chemistry is like that—think of the Periodic
Table,” she says. After receiving her B.S. in chemistry from
Manhattan College in 1986, she got her first job at General
Foods, working on a project seeking to genetically engineer a
decaffeinated coffee bean. This introduction to biochemistry
led her to her next position at Lederle Laboratories. There she
has built a career in molecular biology, working on the develop
ment of vaccines for polio, Norwalk virus, rotavirus and herpes
simplex virus. She is currently with Pfizer’s 13V Pneumococcal
Conjugate Vaccine program. Along the way, she went to New
York Medical College for her M.S. in biochemistry and molecular
biology and wrote her thesis on translation of poliovirus mRNA.
Meanwhile, Blakeney began to explore the world. In 2000,
she went to Africa, first to climb Mount Kilimanjaro and then—
“having sufficiently tired myself out so I could relax in a vehicle”
—on safari. That trip first sparked her interest in other cultures.
But her dream was to go to the Far East, and her colleagues
at Wyeth (which had acquired Lederle Laboratories) supported
her taking a leave of absence to travel. In 2004, she visited
Bhutan, Thailand, and Nepal, primarily trekking and visiting
remote villages where health care was virtually nonexistent.
“The experience really changed me,” she says. While she had
once believed one needed medical training to help people,
she realized she did not have to become a physician, which
was not her natural bent. With the right training, she would be
able to make a difference through educating people and giving
them the tools to help themselves.
Soon after returning to the United States and to Wyeth, she
went back to NYMC, this time in the School of Health Sciences
and Practice in pursuit of an M.P.H. with a concentration in
international public health. As part of the practicum she did a
six-month internship in East Harlem, where she was trained
as a community health worker doing diabetes education.
“This internship was the best experience in my education,” she
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William C. Reha, M.D. ’81, is
president of the Virginia Urological
Association, speaker of the house
of the Medical Society of Virginia,
member of the board of trustees
at Strayer University and has a fulltime private practice in urology in
Woodbridge, Va.

70s

the

Nicholas Bonvicino, M.D. ’79, is
leaving Horizon BCBS of New Jersey
after 14 years as senior medical
director to start a private health care
consulting company, NB Healthcare
Advisors, LLC, to assist providers
in the development of accountable
care entities.

In 2004, she visited Bhutan,
Thailand, and Nepal, primarily
trekking and visiting remote
villages where health care
was virtually nonexistent.
“The experience really
changed me,” she says.
says, “and had the greatest impact on my career and my aspi
rations, along with the support of Dr. Murthy [Padmini Murthy,
M.D., M.P.H., M.S., CHES, the school’s international health
program director].”
Blakeney received her M.P.H. in 2010, after Wyeth was acquired
by Pfizer, Inc. She soon learned of the Pfizer Global Health
Fellows Program, which places people in short term volunteer
assignments with international development organizations. It
sounded like a perfect fit. Her experience with East Harlem
community health education made her a good match for Project
HOPE’s diabetes prevention and care initiative in India, which
leads the world in the prevalence of the disease. She will remain
there through October 2012, lending her expertise and learning
about the culture. The project emphasizes the role of the edu
cator in empowering patients, especially those at risk for the
disease, to take responsibility for their daily care—a sustainable
model of the kind Blakeney most admires. n

Scott Cutler, M.D. ’77, continues to
practice adult psychiatry in Worcester,
Mass., and New York City. His
daughter, Beth Cutler Freedman,
M.D. ’06, recently achieved board
certification in general surgery and
is currently a fellow in breast surgical oncology at Beth Israel Medical
Center/St. Luke’s Roosevelt Hospital
Center in New York.
Nicholas V. Polifroni, M.D. ’77,
chief of orthopedic surgery at
Norwalk Hospital in Connecticut,
received the hospital’s Tracey Award
for leadership, character, community
service involvement and clinical skill.
Michael J. Bronson, M.D. ’76,
was appointed vice chairman of the
Department of Orthopedic Surgery at
The Mount Sinai School of Medicine.
Daniel Morhaim, M.D. ’75, is the
author of The Better End: Surviving
(and Dying) on Your Own Terms in
Today's Modern Medical World, published by Johns Hopkins University
Press. Dr. Morhaim presents the
case that choosing end-of-life care
depends on accurate information
and personal values. He writes, “The
book is about empowerment, dignity
and control in managing medical
crises and end-of-life care.”
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William Wickemeyer, M.D. ’75,
was named Cardiovascular Services
Physician Leader at Mercy Medical
Center–Des Moines, where he is
responsible for implementing key
organization-wide strategies, programmatic decision making, and
communication and collaboration
with medical staff.

60s

the

Richard Fogler, M.D. ’68, chair
man emeritus of the Department of
Surgery, chief medical officer and
designated institutional official at
Brookdale University Hospital and
Medical Center, in Brooklyn, N.Y.,
writes, “The glimmer of retirement is
in sight and the warmth of ‘Zaydehood’ is approaching.”
Morton Meltzer, M.D. ’65, is still
working full-time in psychiatry
but gave up family medicine and
urgent care.
Stephen T. Batthany, M.D. ’64,
resides in Lake Worth, Fla., and is
awaiting an appointment as assistant
clinical professor of family medicine.
He recently spoke with Ira Raff,
M.D. ’64, and Robert Lieberman,
M.D. ’62, and will attend the 50th
reunion.
Stanley Ostern, M.D. ’60, is happily retired in Santa Barbara and
enjoying his 11 grandchildren. He
underwent aortic valve replacement
surgery several months ago and is
happy to report that he is able to
play tennis six days a week. “Not
bad for someone who just had his
77th birthday,” he writes. He is
involved in a program that teaches
troubled youth about the Holocaust,
and he would enjoy hearing from
classmates.

50s

the

Ronald Pion, M.D. ’56, continues to
offer strategic advice to early stage
companies that use innovative and
disruptive technologies.
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Timothy Hsieh, M.D. ’98:
AN EASTERNER, NOW AT HOME
IN OKLAHOMA
By Andrea Kott, M.P.H.

After completing his training in internal medicine and geriatrics
in 2003, Dr. Hsieh moved to Tahlequah to work in a clinic at the
W.W. Hastings Hospital, a 60–70 bed facility that is part of the
Indian Health Service under the U.S. Department of Health and
Human Services. The Cherokee Nation operates the hospital,
which cares exclusively for Native Americans of all tribes.
Dr. Hsieh had expected to stay for three years, under the terms
of his National Health Service Corps scholarship, which requires
one year of service in an underserved area for every year of
financial support provided. And, he did. But he missed family
back east, so in 2006 he accepted a private practice position in
State College, Pennsylvania. Once there, although he was in the
same time zone, he found the new job did not give him enough
time to spend with family.
Moreover, he was spread too thin to be able to provide con
tinuous, individual patient care. Thus, one year after leaving
Hastings Hospital, Dr. Hsieh returned, and in 2010 he joined its
four-person hospitalist team. As a hospitalist, Dr. Hsieh is able
to address patients’ needs as they occur throughout the day—
faster than a primary care physician who visits only once a day
or sees them briefly in a clinic. “In a clinic setting patients show
up with chronic problems that require lifelong management,” he
says. “If you have many patients waiting for you, you see them
quickly and may not address them again until the next office
visit. Hospitalists get satisfaction from seeing the results of fixing
acute problems.”
Such continuity is critical for treating acute presentations of
chronic medical problems like diabetes, hypertension, chronic
obstructive pulmonary disease, congestive heart failure and
coronary artery disease, which are prevalent in the Native
American population and require ongoing monitoring. As part of
the rapid response team, hospitalists can also respond to acute
and sometimes urgent life-threatening situations.
Following cases from admission to discharge allows hospitalists
to develop good rapport with patients, which is especially
important in the Native American community, whose traditions

A LU M N I N EWS

Photo courtesy of Cherokee Nation Communications.

Tahlequah, Oklahoma, is not where Timothy Hsieh, M.D. ’98,
expected to live after graduating from medical school. And,
once he left, it is not where he expected to return. But between
becoming a physician and raising a family, Dr. Hsieh found he
needed balance, and that is what brought him back.

“The Cherokee Nation
operates the hospital, which
cares exclusively for Native
Americans of all tribes.”
and beliefs may foment distrust of Western medical care.
“Language could be a hindrance to educating Native Americans
about why we’re giving them medicine,” Dr. Hsieh says, adding,
“I’ve had patients who seek their own healers.”
It has been nearly a decade since Dr. Hsieh first arrived at
Hastings Hospital, and in that time he has found the balance
between work and family life. His every-other-week schedule
allows him quality time with daughter Lauren, 8, and son Daniel,
2. He has room for professional growth and recently became a
board-certified sleep specialist. He also has time to teach medi
cal students and residents at Oklahoma State University for
Health Sciences, where he is an adjunct clinical assistant pro
fessor of internal medicine. Plus, Tahlequah is an affordable
place to live and a great place to raise children, he says, adding,
“I would never in a million years think I’d be in Oklahoma.” Not
only there, but there and back again—just like home. n
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1: The Class of 1962.

4: The Class of 1987.

2: M
 edal of Honor winners Robert J. Belsole, M.D. ’69, and
Eileen Dieck, M.D. ’86, with Edward C. Halperin, M.D.,
M.A., the College’s new chancellor and CEO.

5: E ileen Dieck, M.D. ’86, left, Henry Saphier, M.D. ’61, and
Joseph F. Dursi, M.D. ’59 (right), with winners of the
2012 Alumni Endowed Scholarships.

3: Mickey and Henry Saphier, M.D. ’61, president-elect of
the Alumni Association Board of Governors.
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